BioStem Technologies is a leading medical technology company specializing in advanced wound care and regenerative medicine. The company focuses on the development and commercialization of placental tissue allografts, innovative wound care products, and surgical solutions designed to enhance patient outcomes. With a commitment to improving healthcare, BioStem Technologies actively engages with commercial hospitals, physician offices, wound care centers, and Federal Government accounts, including Veterans Affairs and active-duty military hospitals, to expand its market presence and support patient care.